Sponsored
by Anemocyte
How Can We Tackle the Bottleneck in Plasmid Production for Gene Therapies?
The cell and gene therapy sector is booming. At the end of 2019, there were…
February 3, 2020 - 5 minutes
CAR-T Cell Therapy: Revolutionizing Oncology One Step at a Time
The idea that our immune system can be rewired to fight cancer has resulted in huge expectations and an influx of investments into the immuno-oncology field. Following the market success of immune checkpoint inhibitors, more and more attention is turning to CAR-T cell therapy, with the first CAR-T therapy, Novartis’ Kymriah, approved in 2017.
With five CAR-T therapies on the global market already and over hundreds of clinical trials currently running, the field is now booming. Read on to keep up-to-date with the evolving CAR-T cell therapy market and ongoing research.
Show More
Editor's Picks for CAR-T
- A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
- Infographic: What is CAR-T Cell Therapy & How Does it Fight Cancer?
- From Big Pharma to Startup CEO: Lessons from Kymriah Developer Gaurav Shah
- Gene-Edited T Cell Therapy Players Battle Safety Doubts
- How European Startups Have Advanced Cancer T-Cell Therapy in 2020
A Guide to Current Therapies in Immuno-Oncology
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade. In this report, we look into its past, discuss present therapeutic approaches, and provide an outlook into its future.
Go to ReportLatest CAR-T Articles
T-Cell Discovery Could Herald Universal Cancer Immunotherapy
An international research team has found a new type of T-cell that could lead to…
January 21, 2020 - 3 minutes
Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas
The UK biotech Adaptimmune Therapeutics has inked a deal worth up to €806M with Japanese…
January 15, 2020 - 2 minutes
BioNTech’s RNA-Boosted CAR T-Cell Therapy Shrinks Tumors in Mice
A CAR T-cell therapy amplified by RNA technology, developed by BioNTech, has shown preclinical potential…
January 6, 2020 - 2 minutes
European Biotech’s Top News in 2019
With the year coming to a close, it’s time to review the most important biotech…
December 30, 2019 - 10 minutes
Autolus Reveals Early Clinical Data of Next-Gen CAR-T Therapy
London-based Autolus has shown its next-generation CAR T-cell therapy does not induce some of the…
December 9, 2019 - 4 minutes
Cellectis’ Off-the-Shelf CAR T-Cell Therapy Shows Solid Tumor Potential
An off-the-shelf, gene edited CAR T-cell therapy, developed by the French biotech Cellectis, could be…
November 14, 2019 - 2 minutes
First Results Out for Off-the-Shelf CAR-T Therapy in Solid Tumors
The Belgian company Celyad has released the first interim clinical efficacy data for an off-the-shelf…
November 12, 2019 - 2 minutes
This Biotech Can Screen CAR T-Cells Using Only Light and Microfluidics
Based in Cambridge, UK, Lightcast Discovery is developing microfluidics technology that automates cell screening experiments…
September 27, 2019 - 3 minutes
Manufacturing Delays Set Back Autolus’ CAR-T Programs by Five Months
The UK biotech Autolus’ shares have slumped as construction delays from a new manufacturing site…
August 12, 2019 - 2 minutes
Will T Cells Cure Cancer Soon?
As an important part of the adaptive immune system, T cells play an essential role…
July 22, 2019 - 9 minutes
Gamma Delta T Cells: A New Hope Against Cancer
A new wave of therapies based on a unique type of immune cells, called gamma…
June 11, 2019 - 5 minutes
